A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

NCT07326137 · clinicaltrials.gov ↗

RECRUITING

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Cancer(BTC)
Advanced Pancreatic Cancers
Cancer-related Pain

Interventions

DRUG: First-Line Systemic Therapy
PROCEDURE: Celiac Plexus Neurolysis (CPN)

Sponsor

Tongji Hospital